Investigation into Sillajen Intensifies... Prosecutors Request Arrest Warrants for Former CEO Lee Yong-han and One Other
[Asia Economy Reporter Yoo Byung-don] The prosecution investigating allegations of insider trading involving the bio company Sillajen has secured the custody of key suspects.
The Financial Investigation Division 1 of the Seoul Southern District Prosecutors' Office (Chief Prosecutor Seo Jeong-sik) announced on the 10th that it filed arrest warrants for former CEO Lee Yong-han (54) and former auditor Kwak Byung-hak (56) of Sillajen the previous day.
They are suspected of using internal company information to sell large amounts of stock before the public disclosure of the suspension of clinical trials for Sillajen's immuno-oncology drug 'Pexavac,' thereby avoiding significant losses.
Sillajen's stock price once soared on expectations for Pexavac's development but plummeted after the suspension of clinical trials was revealed.
Lee served as CEO from 2008 to 2009, and Kwak, a relative of current CEO Moon Eun-sang (55), served as auditor and inside director of the company from 2012 to 2016.
Hot Picks Today
"Samsung Electronics Employee With 100 Million Won Salary" to Receive 600 Million Won Bonus... Estimated Tax Released
- At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- Dressed in Leather, Jensen Huang Eats 8,400 Won Noodles in a Hurry... Instantly Turns Shop into a Hotspot
- "4.15 Million Won Prada Jacket Shows White Spots After One Wear"...Korea Consumer Agency Orders Full Refund
Meanwhile, the prosecution has been continuing its investigation since raiding Sillajen in August last year.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
